A citation-based method for searching scientific literature

M R Wevers, N K Aaronson, S Verhoef, E M A Bleiker, D E E Hahn, M A Kuenen, J van der Sanden-Melis, T Brouwer, F B L Hogervorst, R B van der Luijt, H B Valdimarsdottir, T van Dalen, E B M Theunissen, B van Ooijen, M A de Roos, P J Borgstein, B C Vrouenraets, E Vriens, W H Bouma, H Rijna, J P Vente, A J Witkamp, E J T Rutgers, M G E M Ausems. Br J Cancer 2014
Times Cited: 20







List of co-cited articles
115 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.
Marc D Schwartz, Caryn Lerman, Barbara Brogan, Beth N Peshkin, Chanita Hughes Halbert, Tiffani DeMarco, William Lawrence, David Main, Clinton Finch, Colette Magnant,[...]. J Clin Oncol 2004
190
35

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis.
Kelly Metcalfe, Shelley Gershman, Parviz Ghadirian, Henry T Lynch, Carrie Snyder, Nadine Tung, Charmaine Kim-Sing, Andrea Eisen, William D Foulkes, Barry Rosen,[...]. BMJ 2014
158
35

A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive Italian women.
L Cortesi, E Razzaboni, A Toss, E De Matteis, I Marchi, V Medici, G Tazzioli, A Andreotti, G De Santis, M Pignatti,[...]. Ann Oncol 2014
24
35


Preoperative genetic testing affects surgical decision making in breast cancer patients.
Elizabeth Lokich, Ashley Stuckey, Christina Raker, Jennifer Scalia Wilbur, Jessica Laprise, Jennifer Gass. Gynecol Oncol 2014
28
25

Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Marc D Schwartz, Heiddis B Valdimarsdottir, Beth N Peshkin, Jeanne Mandelblatt, Rachel Nusbaum, An-Tsun Huang, Yaojen Chang, Kristi Graves, Claudine Isaacs, Marie Wood,[...]. J Clin Oncol 2014
159
25

Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .
Allison W Kurian, Kent A Griffith, Ann S Hamilton, Kevin C Ward, Monica Morrow, Steven J Katz, Reshma Jagsi. JAMA 2017
69
25

Breast cancer in women at high risk: the role of rapid genetic testing for BRCA1 and -2 mutations and the consequences for treatment strategies.
Anne Brecht Francken, Philip C Schouten, Eveline M A Bleiker, Sabine C Linn, Emiel J Th Rutgers. Breast 2013
16
25


Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
Anita Y Kinney, Karin M Butler, Marc D Schwartz, Jeanne S Mandelblatt, Kenneth M Boucher, Lisa M Pappas, Amanda Gammon, Wendy Kohlmann, Sandra L Edwards, Antoinette M Stroup,[...]. J Natl Cancer Inst 2014
77
20

Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
Amanda K Arrington, Stephanie L Jarosek, Beth A Virnig, Elizabeth B Habermann, Todd M Tuttle. Ann Surg Oncol 2009
178
20

Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? results from a randomized clinical trial.
Marijke R Wevers, Margreet G E M Ausems, Senno Verhoef, Eveline M A Bleiker, Daniela E E Hahn, Titia Brouwer, Frans B L Hogervorst, Rob B van der Luijt, Thijs van Dalen, Evert B Theunissen,[...]. Genet Med 2016
19
21

Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.
Akiko Chiba, Tanya L Hoskin, Emily J Hallberg, Jodie A Cogswell, Courtney N Heins, Fergus J Couch, Judy C Boughey. Ann Surg Oncol 2016
25
20

Rapid genetic counseling and testing in newly diagnosed breast cancer: Patients' and health professionals' attitudes, experiences, and evaluation of effects on treatment decision making.
Marijke R Wevers, Neil K Aaronson, Eveline M A Bleiker, Daniela E E Hahn, Titia Brouwer, Thijs van Dalen, Evert B Theunissen, Bart van Ooijen, Marnix A de Roos, Paul J Borgstein,[...]. J Surg Oncol 2017
9
44

Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients.
Marc D Schwartz, Beth N Peshkin, Claudine Isaacs, Shawna Willey, Heiddis B Valdimarsdottir, Rachel Nusbaum, Gillian Hooker, Suzanne O'Neill, Lina Jandorf, Scott P Kelly,[...]. Breast Cancer Res Treat 2018
10
40

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
498
15

Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing.
Bettina Meiser, Margaret Gleeson, Kaaren Watts, Michelle Peate, Elvira Zilliacus, Kristine Barlow-Stewart, Christobel Saunders, Gillian Mitchell, Judy Kirk. Oncol Nurs Forum 2012
22
15

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
K Metcalfe, S Gershman, H T Lynch, P Ghadirian, N Tung, C Kim-Sing, O I Olopade, S Domchek, J McLennan, A Eisen,[...]. Br J Cancer 2011
120
15

Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.
Dorina M van der Kolk, Geertruida H de Bock, Beike K Leegte, Michael Schaapveld, Marian J E Mourits, Jakob de Vries, Annemieke H van der Hout, Jan C Oosterwijk. Breast Cancer Res Treat 2010
116
15

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
15

BRCA in breast cancer: ESMO Clinical Practice Guidelines.
J Balmaña, O Díez, I T Rubio, F Cardoso. Ann Oncol 2011
116
15

The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study.
Kerstin Rhiem, Christoph Engel, Monika Graeser, Silke Zachariae, Karin Kast, Marion Kiechle, Nina Ditsch, Wolfgang Janni, Christoph Mundhenke, Michael Golatta,[...]. Breast Cancer Res 2012
58
15

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
L C Hartmann, T A Sellers, D J Schaid, T S Frank, C L Soderberg, D L Sitta, M H Frost, C S Grant, J H Donohue, J E Woods,[...]. J Natl Cancer Inst 2001
478
15

BRCA testing of breast cancer patients: medical specialists' referral patterns, knowledge and attitudes to genetic testing.
E Van Riel, C C Wárlám-Rodenhuis, S Verhoef, E J T H Rutgers, M G E M Ausems. Eur J Cancer Care (Engl) 2010
38
15

Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda.
Bettina Meiser, Kathy Tucker, Michael Friedlander, Kristine Barlow-Stewart, Elizabeth Lobb, Christobel Saunders, Gillian Mitchell. Breast Cancer Res 2008
40
15

How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.
Kaaren J Watts, Bettina Meiser, Gillian Mitchell, Judy Kirk, Christobel Saunders, Michelle Peate, Jessica Duffy, Patrick J Kelly, Margaret Gleeson, Kristine Barlow-Stewart,[...]. BMC Cancer 2012
20
15

BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy.
Kathryn J Schlich-Bakker, Margreet G E M Ausems, Maria Schipper, Herman F J Ten Kroode, Carla C Wárlám-Rodenhuis, Jan van den Bout. Breast Cancer Res Treat 2008
31
15


Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.
Kathleen E Malone, Colin B Begg, Robert W Haile, Ake Borg, Patrick Concannon, Lina Tellhed, Shanyan Xue, Sharon Teraoka, Leslie Bernstein, Marinela Capanu,[...]. J Clin Oncol 2010
111
15

Disparities in genetic testing: thinking outside the BRCA box.
Michael J Hall, Olufunmilayo I Olopade. J Clin Oncol 2006
120
15



Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients.
T Byrski, T Huzarski, R Dent, E Marczyk, M Jasiowka, J Gronwald, J Jakubowicz, C Cybulski, R Wisniowski, D Godlewski,[...]. Breast Cancer Res Treat 2014
156
15

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
849
15

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
Kelly Metcalfe, Henry T Lynch, Parviz Ghadirian, Nadine Tung, Ivo Olivotto, Ellen Warner, Olufunmilayo I Olopade, Andrea Eisen, Barbara Weber, Jane McLennan,[...]. J Clin Oncol 2004
420
15

Surgical decisions made by 158 women with hereditary breast cancer aged <50 years.
D G R Evans, F Lalloo, P Hopwood, A Maurice, A Baildam, A Brain, L Barr, A Howell. Eur J Surg Oncol 2005
35
15

Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.
Min Yi, Kelly K Hunt, Banu K Arun, Isabelle Bedrosian, Angelica Gutierrez Barrera, Kim-Anh Do, Henry M Kuerer, Gildy V Babiera, Elizabeth A Mittendorf, Kaylene Ready,[...]. Cancer Prev Res (Phila) 2010
117
15

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.
T C van Sprundel, M K Schmidt, M A Rookus, R Brohet, C J van Asperen, E J Th Rutgers, L J Van't Veer, R A E M Tollenaar. Br J Cancer 2005
178
15

Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis.
Jeffrey N Weitzel, Sarah M McCaffrey, Raluca Nedelcu, Deborah J MacDonald, Kathleen R Blazer, Carey A Cullinane. Arch Surg 2003
120
15

Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
Marc D Schwartz, Caryn Lerman, Barbara Brogan, Beth N Peshkin, Claudine Isaacs, Tiffani DeMarco, Chanita Hughes Halbert, Marie Pennanen, Clinton Finch. Cancer Epidemiol Biomarkers Prev 2005
66
15

Breast Cancer Genetic Counseling: A Surgeon's Perspective.
Doreen M Agnese, Raphael E Pollock. Front Surg 2016
7
42

Barriers to genetic testing in newly diagnosed breast cancer patients: Do surgeons limit testing?
Laura Hafertepen, Alyssa Pastorino, Nichole Morman, Jennifer Snow, Deepa Halaharvi, Lindsey Byrne, Mark Cripe. Am J Surg 2017
13
23

Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.
Allison W Kurian, Bronislava M Sigal, Sylvia K Plevritis. J Clin Oncol 2010
155
10

The Angelina Jolie effect.
Paul A James, Gillian Mitchell, Michael Bogwitz, Geoffrey J Lindeman. Med J Aust 2013
23
10

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
Allison W Kurian, Emily E Hare, Meredith A Mills, Kerry E Kingham, Lisa McPherson, Alice S Whittemore, Valerie McGuire, Uri Ladabaum, Yuya Kobayashi, Stephen E Lincoln,[...]. J Clin Oncol 2014
312
10

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
10


Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
10


Communication and information needs of women diagnosed with ovarian cancer regarding treatment-focused genetic testing.
Margaret Gleeson, Bettina Meiser, Kristine Barlow-Stewart, Alison H Trainer, Kathy Tucker, Kaaren J Watts, Michael Friedlander, Nadine Kasparian. Oncol Nurs Forum 2013
28
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.